Emily Fisher, founder and CEO of Leafwell, is empowering patients with the knowledge and support they need to integrate cannabis into their treatment plans.
According to the joint motion, both parties expect that FDA's response to NPA's citizen petition on the matter will resolve the drug preclusion-related case.
In the three decades since landmark legislation framed the marketplace, dietary supplements have proliferated, offering consumers an expanding menu of products.